Arzu Karabay

1.0k total citations
31 papers, 804 citations indexed

About

Arzu Karabay is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Arzu Karabay has authored 31 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Cell Biology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Arzu Karabay's work include Microtubule and mitosis dynamics (14 papers), Ubiquitin and proteasome pathways (12 papers) and Signaling Pathways in Disease (6 papers). Arzu Karabay is often cited by papers focused on Microtubule and mitosis dynamics (14 papers), Ubiquitin and proteasome pathways (12 papers) and Signaling Pathways in Disease (6 papers). Arzu Karabay collaborates with scholars based in Türkiye, United States and Germany. Arzu Karabay's co-authors include Peter W. Baas, Liang Qiang, Şirin Korulu, Joanna M. Solowska, Wenqian Yu, R. A. Walker, Douglas H. Baird, Kutay Deniz Atabay, Yeşim Neğiş and Meral Yüksel and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Arzu Karabay

29 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arzu Karabay Türkiye 13 479 461 229 71 68 31 804
Elena Tortosa Spain 17 507 1.1× 473 1.0× 312 1.4× 108 1.5× 64 0.9× 18 916
Joanna Lipka Netherlands 8 435 0.9× 551 1.2× 215 0.9× 54 0.8× 44 0.6× 10 800
Chandra S. Malladi Australia 12 420 0.9× 536 1.2× 214 0.9× 30 0.4× 37 0.5× 23 816
Stevan Djakovic United States 10 323 0.7× 658 1.4× 168 0.7× 33 0.5× 138 2.0× 14 913
Kamil J. Alzayady United States 18 315 0.7× 889 1.9× 198 0.9× 53 0.7× 82 1.2× 26 1.2k
Harald Witte Switzerland 8 402 0.8× 540 1.2× 362 1.6× 184 2.6× 64 0.9× 11 977
Yogesh P. Wairkar United States 10 391 0.8× 530 1.1× 373 1.6× 25 0.4× 57 0.8× 17 826
Sylvie Ozon France 14 578 1.2× 606 1.3× 311 1.4× 145 2.0× 39 0.6× 15 1.1k
Max Adrian Netherlands 10 189 0.4× 354 0.8× 242 1.1× 30 0.4× 24 0.4× 17 602
Toshihide Kimura Japan 11 497 1.0× 554 1.2× 575 2.5× 201 2.8× 63 0.9× 12 1.1k

Countries citing papers authored by Arzu Karabay

Since Specialization
Citations

This map shows the geographic impact of Arzu Karabay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arzu Karabay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arzu Karabay more than expected).

Fields of papers citing papers by Arzu Karabay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arzu Karabay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arzu Karabay. The network helps show where Arzu Karabay may publish in the future.

Co-authorship network of co-authors of Arzu Karabay

This figure shows the co-authorship network connecting the top 25 collaborators of Arzu Karabay. A scholar is included among the top collaborators of Arzu Karabay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arzu Karabay. Arzu Karabay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karabay, Arzu, et al.. (2023). miR96‐ and miR182‐driven regulation of cytoskeleton results in inhibition of glioblastoma motility. Cytoskeleton. 80(9-10). 367–381. 3 indexed citations
3.
Baslo, Mehmet Barış, et al.. (2022). MYO1H is a novel candidate gene for autosomal dominant pure hereditary spastic paraplegia. Molecular Genetics and Genomics. 297(4). 1141–1150.
4.
Piermarini, Emanuela, Theresa Connors, Matthias Kneussel, et al.. (2021). Modeling gain-of-function and loss-of-function components ofSPAST-based hereditary spastic paraplegia using transgenic mice. Human Molecular Genetics. 31(11). 1844–1859. 7 indexed citations
5.
Kocabay, Gönenç, et al.. (2020). Insulin-like growth factor-1 levels predict myocardial injury and infarction after elective percutaneous coronary intervention: an optical coherence tomography study. Advances in Interventional Cardiology. 16(2). 162–169. 2 indexed citations
6.
Erman, Batu, et al.. (2019). p53 regulates katanin-p60 promoter in HCT 116 cells. Gene. 727. 144241–144241. 6 indexed citations
7.
Karabay, Arzu, et al.. (2019). Elk1 affects katanin and spastin proteins via differential transcriptional and post-transcriptional regulations. PLoS ONE. 14(2). e0212518–e0212518. 9 indexed citations
8.
Gezen‐Ak, Duygu, Erdinç Dursun, İrem L. Atasoy, et al.. (2018). Okadaic acid–induced tau hyperphosphorylation and the downregulation of Pin1 expression in primary cortical neurons. Journal of Chemical Neuroanatomy. 92. 41–47. 18 indexed citations
9.
Koparır, Asuman, Ömer Faruk Karataş, Bayram Yüksel, et al.. (2015). NovelPOC1Amutation in primordial dwarfism reveals new insights for centriole biogenesis. Human Molecular Genetics. 24(19). 5378–5387. 26 indexed citations
10.
Korulu, Şirin, et al.. (2015). Neuroprotective strategies against calpain-mediated neurodegeneration. Neuropsychiatric Disease and Treatment. 11. 297–297. 49 indexed citations
11.
Atabay, Kutay Deniz, Mehmet Taha Yıldız, Timuçin Avşar, Arzu Karabay, & Türker Kılıç. (2015). Knockdown of Pin1 leads to reduced angiogenic potential and tumorigenicity in glioblastoma cells. Oncology Letters. 10(4). 2385–2389. 6 indexed citations
12.
Korulu, Şirin, et al.. (2013). Katanin-p80 Gene Promoter Characterization and Regulation via Elk1. PLoS ONE. 8(7). e69423–e69423. 12 indexed citations
13.
Atabay, Kutay Deniz & Arzu Karabay. (2011). Pin1 inhibition activates cyclin D and produces neurodegenerative pathology. Journal of Neurochemistry. 120(3). 430–439. 15 indexed citations
14.
Neğiş, Yeşim, et al.. (2011). Cell cycle markers have different expression and localization patterns in neuron-like PC12 cells and primary hippocampal neurons. Neuroscience Letters. 496(2). 135–140. 11 indexed citations
15.
Karabay, Arzu, et al.. (2010). Production and Characterization of a Monoclonal Antibody Against P60-Katanin. Hybridoma. 29(6). 531–537. 1 indexed citations
16.
Yu, Wenqian, Liang Qiang, Joanna M. Solowska, et al.. (2008). The Microtubule-severing Proteins Spastin and Katanin Participate Differently in the Formation of Axonal Branches. Molecular Biology of the Cell. 19(4). 1485–1498. 209 indexed citations
17.
Demir, Özlem, et al.. (2008). Elk-1 interacts with neuronal microtubules and relocalizes to the nucleus upon phosphorylation. Molecular and Cellular Neuroscience. 40(1). 111–119. 17 indexed citations
18.
Baas, Peter W., Arzu Karabay, & Liang Qiang. (2005). Microtubules cut and run. Trends in Cell Biology. 15(10). 518–524. 117 indexed citations
19.
Wendt, Thomas, Arzu Karabay, Angelika Krebs, et al.. (2003). A Structural Analysis of the Interaction between ncd Tail and Tubulin Protofilaments. Journal of Molecular Biology. 333(3). 541–552. 20 indexed citations
20.
Karabay, Arzu & R. A. Walker. (2003). Identification of Ncd tail domain-binding sites on the tubulin dimer. Biochemical and Biophysical Research Communications. 305(3). 523–528. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026